"Dr. Hafron highlights the most significant prostate cancer treatment a" by Jason M. Hafron
 

Dr. Hafron highlights the most significant prostate cancer treatment advances in 2022

Document Type

Multimedia

Publication Date

12-13-2022

Publication Title

Urology Times

Abstract

In this interview, Jason M. Hafron, MD, recaps the biggest advances in the prostate cancer treatment paradigm in 2022. Hafron is a partner at the Michigan Institute of Urology, PC; an associate professor of Urology at the William Beaumont School of Medicine, Oakland University; and the director of Robotic Surgery at Beaumont Hospital Royal Oak in Michigan.

Link to Full Text

Plum Print visual indicator of research metrics
PlumX Metrics
  • Usage
    • Abstract Views: 24
see details

Share

COinS